Skip to main content

REDCap application to be available on commercial market

Feb. 11, 2016, 9:41 AM

A version of a Web application developed at Vanderbilt University that helps academic scientists around the globe collect and manage their research data will soon be available on the commercial market.

REDCap, short for Research Electronic Data Capture, has been licensed to nPhase Inc., a cloud-based technology company that is developing a commercial version of the REDCap application, called REDCap Cloud (, for research universities and companies conducting or participating in clinical trials.

The current non-commercial version of REDCap was created in 2004 by Paul Harris, Ph.D., director of the Vanderbilt Office of Research Informatics. It is licensed at no cost, but only to not-for-profit organizations.

As of last month, Vanderbilt had licensed REDCap to nearly 2,000 institutions in 96 countries, where it is being used by more than 300,000 researchers in more than 217,000 different projects.

“We are delighted to have the opportunity to work with nPhase to build a robust, hosted REDCap solution for industry partners and academic research institutions conducting formal clinical trials,” said Harris, professor of Biomedical Informatics and Biomedical Engineering.

“REDCap is routinely used by academic institutions, non-profit organizations and government agencies around the world to support clinical and translational research,” he said. “We believe that nPhase’s hosted, commercial version of REDCap will provide great value in launching and operationalizing clinical trials.”

“We are very excited to partner with Dr. Harris and Vanderbilt University Medical Center to bring their ground-breaking clinical research technology to market as a cost-effective and widely accessible cloud-based solution,” said nPhase CEO Scott Climes.

“REDCap has been in continuous development and deployment for more than 10 years with feedback from a consortium of the world’s leading research organizations,” Climes said. “We look forward to working with the global research community to bring life science discoveries to market more quickly and efficiently with REDCap Cloud.”

REDCap Cloud is being developed with significant input from Vanderbilt and other prominent research institutions that use e-clinical solutions for regulated clinical trials.

It will be offered as a Software as a Service (SaaS) and will comply with 21 CFR Part 11 and the Federal Information and Security Management Act to support industry and government sponsored clinical research trials, Vanderbilt officials said.

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice